Overcoming inefficiencies in clinical research by fostering a systems approach and core competencies for biomedical professionals involved in medicines development
Keywords:
Biopharmaceutical industry, clinical research, medicines development, competency-based education.Abstract
Clinical trials constitute the largest single component in medicines development, representing nearly 40% of the related expenses. However, there is broad agreement that the current clinical trial system is inefficient. The biopharmaceutical industry, governments, regulatory agencies, academic researchers, the medical profession, and the media should work collaboratively and create efficient clinical trial networks.
Los estudios clínicos representan casi el 40 % de los gastos de desarrollo de nuevos medicamentos. Sin embargo, el sistema actual de investigación clínica es considerado ineficiente e insostenible. La industria farmacéutica, las agencias regulatorias, investigadores clínicos y académicos, la profesión médica y los medios de comunicación masiva deberían trabajar en colaboración para crear redes eficientes de sitios de investigación.
Downloads
